Malignant gastrointestinal stromal tumours treated with imatinib in France: results in unselected patients

被引：0
|
作者：
Bouche, O. [1 ]
Cioffi, A. [2 ]
Rios, M. [3 ]
Blesius, A. [4 ]
Chaigneau, L. [5 ]
Ray-Coquard, I. [6 ]
Blay, J. Y.
Le Cesne, A. [2 ]
Bisot-Locard, S.
Deschaseaux, C. [7 ]
机构：
[1] CHU Reims, Serv Hepatogastroenterol & Cancerol Digest, Reims, France
[2] Inst Gustave Roussy, Villejuif, France
[3] Ctr Alexis Vautrin, Vandoeuvre Les Nancy, France
[4] Hop Enfants La Timone, Marseille, France
[5] Hop Jean Minjoz, F-25030 Besancon, France
[6] Ctr Leon Berard, Dept Oncol Med Adulte, F-69373 Lyon, France
[7] Novartis Pharmaceut, Market Access, Rueil Malmaison, France
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)72003-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：594 / 594
页数：1
相关论文
共 50 条
  • [21] Hepatitis B Virus Reactivation in Gastrointestinal Stromal Tumor Patients Treated With Imatinib
    Lei, Tianxiang
    Tan, Fengbo
    Hou, Zhouhua
    Liu, Peng
    Zhao, Xianhui
    Liu, Heli
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [22] Risk Factors for Gastrointestinal Stromal Tumor Recurrence in Patients Treated With Adjuvant Imatinib
    Joensuu, Heikki
    Eriksson, Mikael
    Hall, Kirsten Sundby
    Hartmann, Joerg T.
    Pink, Daniel
    Schuette, Jochen
    Ramadori, Giuliano
    Hohenberger, Peter
    Duyster, Justus
    Al-Batran, Salah-Eddin
    Schlemmer, Marcus
    Bauer, Sebastian
    Wardelmann, Eva
    Sarlomo-Rikala, Maarit
    Nilsson, Bengt
    Sihto, Harri
    Ballman, Karla V.
    Leinonen, Mika
    DeMatteo, Ronald P.
    Reichardt, Peter
    CANCER, 2014, 120 (15) : 2325 - 2333
  • [23] Imatinib for the treatment of patients with unresectable or metastatic malignant KIT-positive gastrointestinal stromal tumours :: an open-label Belgian trial
    Prenen, Hans
    Dumez, Herlinde
    Stefan, Cristiana
    Hoeben, Ann
    Wouters, Carine
    Van Lierde, Marie-Anne
    Sciot, Raf
    van Oosterom, Allan T.
    Peeters, Marc
    Polus, Marc
    Duck, Lionel
    Gil, Thierry
    Schoffski, Patrick
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2006, 69 (04) : 367 - 371
  • [24] Gastrointestinal stromal tumours-results of molecular testing in Slovenian patients
    Strazar, Z. Dolenc
    Glavac, D.
    VIRCHOWS ARCHIV, 2014, 465 : S146 - S146
  • [25] The role of Imatinib in the neo-adjuvant setting in patients undergoing resection for gastrointestinal stromal tumours
    Madhavan, Anantha
    Phillips, Alexander
    Willows, Rebecca
    Immanuel, Arul
    Verril, Mark
    Griffin, Selwyn Michael
    BRITISH JOURNAL OF SURGERY, 2017, 104 : 51 - 51
  • [26] Resection of focally progressive gastrointestinal stromal tumours resistant to imatinib therapy
    Tse, G. H.
    Wong, E. H. C.
    O'Dwyer, P. J.
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2012, 10 (06): : 309 - 313
  • [27] Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation
    Wilson, J
    Connock, M
    Song, F
    Yao, G
    Fry-Smith, A
    Raftery, J
    Peake, D
    HEALTH TECHNOLOGY ASSESSMENT, 2005, 9 (25) : IX - +
  • [28] Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib
    Gunhild Mechtersheimer
    Gerlinde Egerer
    Manfred Hensel
    Ralf J. Rieker
    Martin Libicher
    Thomas Lehnert
    Roland Penzel
    Virchows Archiv, 2004, 444 : 108 - 118
  • [29] Cost Effectiveness of Imatinib Mesylate in the Treatment of Advanced Gastrointestinal Stromal Tumours
    Daniel M. Huse
    Margaret von Mehren
    Gregory Lenhart
    Heikki Joensuu
    Charles Blanke
    Weiwei Feng
    Stan Finkelstein
    George Demetri
    Clinical Drug Investigation, 2007, 27 : 85 - 93
  • [30] Management of gastrointestinal stromal tumours in the Imatinib era: a surgeon's perspective
    Date, Ravindra S.
    Stylianides, Nicholas A.
    Pursnani, Kishore G.
    Ward, Jeremy B.
    Mughal, Muntzer M.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2008, 6 (1)
12345